Back to Search
REBECCA SHERRY, PHARMD
PHARMD
Pharmacist
NPI: 1902186638Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
051.292331(IL)
Research & Publications (20)
Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma.
PMID 19410956·Ophthalmology·2009
5-case
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.
PMID 19451549·Blood·2009
3-trial
Prolonged suppression of ecosystem carbon dioxide uptake after an anomalously warm year.
PMID 18800137·Nature·2008
8-other
Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines.
PMID 18765555·Clin Cancer Res·2008
8-other
High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006.
PMID 18457330·Cancer·2008
8-other
Obturator hernia as a cause of recurrent pain in a patient with previously diagnosed endometriosis.
PMID 17880958·Fertil Steril·2008
5-case
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.
PMID 18809613·J Clin Oncol·2008
3-trial
Terson syndrome with bilateral optic nerve sheath hemorrhage.
PMID 17895820·J Neuroophthalmol·2007
5-case
Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade.
PMID 17982122·Clin Cancer Res·2007
2-rct
Determination of the elimination half-life of fibroblast growth factor-23.
PMID 17374707·J Clin Endocrinol Metab·2007
8-other
Divergence of reproductive phenology under climate warming.
PMID 17182748·Proc Natl Acad Sci U S A·2007
8-other
Cancer regression in patients after transfer of genetically engineered lymphocytes.
PMID 16946036·Science·2006
3-trial
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4.
PMID 16710025·J Clin Oncol·2006
8-other
The effects of gp100 and tyrosinase peptide vaccinations on nevi in melanoma patients.
PMID 16640539·J Cutan Pathol·2006
3-trial
Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanoma.
PMID 16638862·Clin Cancer Res·2006
3-trial
Treatment of oligometastases after successful immunotherapy.
PMID 16564448·Semin Radiat Oncol·2006
6-review
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study.
PMID 16283570·Ann Surg Oncol·2005
3-trial
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma.
PMID 16237114·J Immunol·2005
8-other
Isolated intracranial fibromuscular dysplasia presents as stroke in a 19-year-old female.
PMID 16100981·Arq Neuropsiquiatr·2005
5-case
Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.
PMID 16087944·J Clin Oncol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8201 E RIVERSIDE BLVD STE 1022
ROCKFORD, IL 61114 - Phone
- (815) 971-1100
Quick Facts
- NPI
- 1902186638
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile